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Molecular characterization of infectious mouse mammary tumor viruses (MMTVs) has been hampered due to the problem
of cloning a full-length exogenous virus into a plasmid. The present report describes our strategy for obtaining a full-length
clone of an exogenous MMTV from a mouse mammary tumor that arose spontaneously in a wild Chinese mouse free of
endogenous MMTV and shows that the cloned virus (JYG-MMTV) is expressed in rat RBA cells. Four-week-old C58/J 3
CBA/CaJ female mice, free of both endogenous and exogenous MMTVs, were injected with virus-secreting RBA cells. The
progeny of these mice were bred, and their offspring were tested for the presence of MMTV. These third-generation mice
were found to actively produce MMTV that was shed in their milk and transmitted to their offspring. The virus was detected
not only in the mammary glands of these young mice, but also in their spleens and bone marrow. These results suggest that
our plasmid-cloned exogeneous JYG-MMTV is infectious. This virus can now be used effectively in manipulating the various
genes of JYG-MMTV and other MMTV strains to understand their structure/function relationships. © 2000 Academic Press
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FINTRODUCTION
Mouse mammary tumor virus (MMTV), a B-type retro-
virus, was first identified in 1936 as a “milk factor” in
certain strains of mice with a high incidence of breast
cancer (Bittner, 1936). It is now known that there are two
forms of MMTVs: exogeneous MMTVs are transmitted
from mother to the offspring through milk, whereas the
endogenous MMTVs, the majority of which do not pro-
duce infectious viral particles, are proviral integrants and
are transmitted through the germ line (Kozak et al., 1987).
One recent study has indicated the generation in vivo of
infectious MMTVs by recombination between endoge-
nous and exogenous proviruses (Golovkina et al., 1997).
The MMTV provirus is composed of gag, pro, pol, and
env genes and serves as a template for three viral mRNA
transcripts: genomic, envelope (env), and long terminal
repeat (LTR) mRNAs (Sen et al., 1979, 1980; Wheeler et
l., 1983; Van Ooyen et al., 1983). Two copies of the viral
NA genome are packaged into viral particles which are
eleased from mammary cells and shed into the milk.
he viral LTR mRNA translates into a membrane-associ-
ted glycoprotein that has been designated a superan-
igen (SAg) since it leads to in vivo deletion and in vitro
timulation of T cells bearing particular Vb gene prod-
ucts (Acha-Orbea et al., 1991; Choi et al., 1991; Frankel et
al., 1991; Held et al., 1992). SAg seems to play an impor-
1 To whom reprint requests should be addressed. Fax: 706-721-7915.
-mail: nsarkar@mail.mcg.edu.
325ant role in MMTV pathogenesis (Dzuris et al., 1997;
olovkina et al., 1992; Held et al., 1992, 1993).
Mouse mammary tumors develop as a consequence
of the integration of infectious MMTVs next to a family of
protooncogenes such as int-1, int-2, and int-3, which can
e transcriptionally activated by the integrated virus
Dickson et al., 1984; Gallahan and Callahan, 1987;
usse and Varmus, 1982; Nusse et al., 1984; Peters et al.,
983; Sarkar et al., 1994). These protooncogenes are also
nvolved in the control of developmental processes in
ertebrates (Nusse and Varmus, 1992). The expression of
ne of the int genes, int-3, has been shown to be in-
reased dramatically by steroid hormones (Robbins et
l., 1992) that act on the inducible enhancer contained
ithin the viral LTR (Ostrowski et al., 1984; Ucker et al.,
981).
To date, structural and functional studies of exoge-
ous MMTVs have been very difficult. Although the full-
ength proviral DNA of an exogenous MMTV, GR-MMTV,
as successfully cloned into l phage, this clone was
ound to be unstable during phage DNA replication (Mor-
is et al., 1989). Plasmid cloning of full-length exogenous
R6-, GR-, and C3H-MMTV has been obstructed by two
arriers (Brookes et al., 1986; Donehower et al., 1981;
asel et al., 1983; Groner et al., 1980; Majors and Varmus,
1981, 1983; Morris et al., 1989; Peterson et al., 1985;
Salmons et al., 1985; Shackleford and Varmus, 1988; Xu
et al., 1994). First, a “poison” sequence contained within
the gag gene prevents the gag gene from being cloned
into plasmids. The second barrier is that the two LTRs of
the MMTV provirus have a tendency to be deleted when
0042-6822/00 $35.00
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326 XU ET AL.the proviral DNA is amplified in Escherichia coli. How-
ver, it has been possible to construct a hybrid MMTV
Hyb-MMTV) containing the 59 segment of an endoge-
ous MMTV, the Mtv-1, and the 39 segment of an exog-
nous C3H-MMTV (Shackleford and Varmus, 1988). This
yb-MMTV is able to induce mammary tumors in BALB/c
ice that carry three endogenous MMTVs, Mtv-6, Mtv-8,
nd Mtv-9. However, the hybrid virus has recently been
hown to undergo recombination with Mtv-8 and Mtv-9
or the development of mammary tumors in BALB/c mice
Wrona et al., 1998). Reevaluation of the results that
hackleford and Varmus (1988) obtained with their Hyb-
MTV indicates that the tumors they analyzed were
ost likely induced by Hyb-MMTV/Mtv-9 and Hyb-
MTV/Mtv-8 recombinants, because of the fact that the
umor DNA contained amplified copies of a Mtv-9-spe-
ific 2.7-kb MMTV-gag-related PstI/BglII fragment and a
tv-8- and Mtv-9-specific 2.1-kb MMTV-env-related BglII
ragment (see Fig. 6). These observations underscore
he problem of using hybrid MMTVs in studies of the
enetics of exogenous viruses in mouse strains carrying
ndogenous MMTVs.
We reported previously that a novel strain of feral mice
JYG) carrying only exogenous MMTV (JYG-MMTV) de-
elop mammary tumors at a high incidence as a conse-
uence of insertional mutations in int-3 (40%), Wnt-1
33%), and int-2 (13%) (Imai et al., 1994; Sarkar et al.,
994). In contrast, GR- and C3H-MMTVs have been
hown to activate only Wnt-1 and/or int-2, while CzechII-
MTV activates int-3 (Nusse and Varmus, 1982; Dickson
t al., 1984; Gallahan and Callahan, 1987). Furthermore,
R-MMTV and JYG-MMTV differ in host cell range: the
R-MMTV infects both ductal and lobuloalveolar mam-
ary epithelial cells and induces type-B and -P adeno-
arcinomas (Van Nie and Dux, 1971; Sass and Dunn,
979; Van Nie, 1981), whereas JYG-MMTV infects only
obuloalveolar cells and causes only type-B adenocarci-
omas (Imai et al., 1994). These differences in the pat-
erns of MMTV oncogenesis regarding the activation of
ifferent oncogenes in different strains of mice may be
eflected in the genetics of the various structural genes
mong the different exogenous MMTV strains as well as
n the participation of endogenous MMTVs.
In order to understand the basis for the preferential
nfection and activation of Wnt/int genes by MMTV in
ifferent mouse strains, it is imperative that studies of the
iology of the genes of the various exogenous MMTV
trains be undertaken. The most effective approach for
uch analyses may involve (1) plasmid cloning of a par-
icular infectious MMTV, such as JYG-MMTV, (2) con-
truction of chimeric proviruses by switching gene frag-
ents among different exogenous MMTV strains, (3)
tudies of the pattern of viral infection and mammary
umor development in endogenous MMTV-free mice, and
inally (4) analyses of the pattern of int activation in the
umors. To facilitate such studies, we have cloned a
a
bull-length JYG-MMTV in a plasmid and show that the
rovirus is infectious.
RESULTS
econstruction of a full-length JYG-MMTV provirus in
Bluescript SK
Previously, we cloned a 9.4-kb JYG-MMTV provirus
ontaining the 59 LTR-gag-pol-env-39 LTR into pBlue-
cript SK (described as clone No. CL. 11 in Xu et al.,
994). In the present report, this original clone has been
esignated as clone O (CL. O, Fig. 1; the plasmid seg-
ent of the construct is not shown). While this provirus
ontained the open reading frames for the gag, pro, pol,
FIG. 1. Diagram depicting the steps used to construct a full-length
JYG-MMTV provirus (CL. 6; for details see text) from a plasmid clone CL. O
(previously designated as clone No. 11; Xu et al., 1994) of the provirus that
contained truncated long terminal repeats (LTRs). The truncated 59 and 39
LTRs in CL. O have been indicated by two hatched boxes; the clone
contains about 0.9 kb cellular sequences at the 39 end (indicated by a
wavy line). The blank box represents a full-length LTR cloned in plasmid by
PCR (CL. 1). Restriction sites for SalI(S9), ClaI(C), SacI(S), HindIII(H), PstI (P),
EcoRI(E), StuI (St), and XbaI(X) in the provirus have been indicated (see
CL. O and CL. 6). Note that the ClaI(C)/ClaI(C) fragment shown in C was
derived from CL. O. The locations of the gag, pro, pol, and env genes of the
full-length provirus are shown below CL. 6.nd env genes, both the 59 and the 39 LTRs (hatched
oxes) were partially deleted; the 39 end of the viral DNA
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327CLONING OF A MILK-BORNE MOUSE MAMMARY TUMOR VIRUScontained about 0.9 kb cellular sequences. Fortunately,
the deleted LTRs were found to be overlapped by 8 bp.
This allowed us to compile the sequence of a full-length
LTR and to design primers for the PCR amplification of a
full-length LTR fragment to replace the truncated LTRs
contained in clone CL. O (Fig. 1). A full-length LTR was
irectly amplified from the genomic DNA of a JYG mouse
ammary tumor to ensure that only the LTR of exoge-
ous MMTV proviruses was amplified. The amplified
.33-kb LTR product was digested with PstI (P) and SacI
S) and subcloned into pBluescript SK (CL. 1) and se-
uenced. No mutation was found to be present in the
lasmid clone and, therefore, this clone was used to
onstruct a full-length provirus following a number of
teps (Fig. 1). It should be mentioned that our initial
ttempts at cloning this full-length LTR into the gag-pol-
nv fragment failed, as deletion of either the 59 or the 39
LTR occurred frequently when the plasmid was repli-
cated in XL1-Blue E. coli. However, this problem was
readily overcome by using SURE cells (Stratagene) as
the bacterial host.
The plasmid clone (CL. O) containing a truncated JYG-
MMTV proviral fragment (8.33 kb) was first digested with
ClaI (C), and the ClaI-env-D 39 LTR-cellular-pBluescript
SK-ClaI fragment was isolated and then self-ligated (see
Fig. 1: the pBluescript SK-ClaI site is located at the
beginning of the 59 DLTR). This clone (CL. 2) was then
modified by substituting the 1.6-kb PstI-D 39 LTR-cellular
DNA-SacI fragment with a full-length LTR: the ClaI (C)-
env-PstI (P) segment from clone CL. 2 (Fig. 1B) was
combined with the 1.33-kb PstI-LTR-SacI fragment from
clone CL. 1. The resulting clone has been designated
CL. 3. In order to restore the full-length 59 LTR of the
provirus, clone CL. 4 was constructed first by ligating the
SalI (S9)-DLTR-HindIII (H) fragment from CL. O and the
HindIII-59 DLTR-gag-XbaI (X) fragment from clone CL. O
(Fig. 1A) into the SalI/XbaI-digested pBluescript vector.
The ClaI-D59 LTR-gag-pol-env-ClaI fragment was then
isolated from clone CL. O (Fig. 1C) and cloned into the
ClaI site of clone CL. 3 to produce clone CL. 5. The
truncated 59 LTR contained in CL. 5 was then replaced
with a full-length 59 LTR. To accomplish this goal, clone
CL. 5 was digested with XbaI and the XbaI-Dgag-pro-pol-
env-39 LTR fragment (Fig. 1D) was isolated and ligated
with the SalI-59 DLTR-gag-XbaI fragment that was ob-
tained from clone CL. 4 (Fig. 1E; the SalI site in clone
CL. 4 is located within the plasmid). This final step re-
sulted into the development of a plasmid clone (CL. 6) of
a full-length JYG-MMTV provirus.
In order to determine whether the cloned provirus had
undergone any rearrangements or deletions during re-
construction, DNA was digested with the restriction en-
zymes EcoRI (E), PstI (P), StuI (St), HindIII, SacI (S), and
SalI (S9) and analyzed by Southern blotting and hybrid-
ization with full-length MMTV (MMTV-rep; Fig. 2B) and
MMTV-LTR (Fig. 2C), and -gag probes (Fig. 2D). Theradioactive probes were prepared using an oligo-label-
ing kit (Pharmacia). The sizes of the restriction fragments
visualized by ethidium bromide staining (Fig. 2A) and by
the radioactive probes were found to be consistent with
the restriction map of the full-length JYG-MMTV provirus
(compare Figs. 1 and 2). This indicated that no rear-
rangements or deletions occurred within the recon-
structed provirus. As a precaution, we subcloned again
the 39 LTR of the full-length provirus into pBluescript SK
and its nucleotide sequences were determined. No point
mutations were found in the LTR. Taken together, the
results suggested that the cloned provirus was intact
and both the 59 and the 39 LTRs remained unaltered
during DNA amplification in SURE cells.
Evidence for the infectivity of the cloned provirus
MMTV is a slow-growing oncogenic virus and does
FIG. 2. Evidence that the reconstructed full-length JYG-MMTV provi-
rus subcloned in the SalI-SacI sites of pBluescript SK is intact: the
hybridization patterns are consistent with the restriction map of a
full-length JYG-MMTV (see CL. 6 in Fig. 1). The proviral DNA was
digested with EcoRI (E), PstI (P), StuI (St), HindIII (H), and SacI-SalI
S1S9) and then electrophoresed. The gel was stained with ethidium
romide (A) and subsequently hybridized with full-length MMTV
MMTV-rep; (B), MMTV-LTR (C), and MMTV-gag (D) probes. The frag-
ents of defined sizes that were expected to be produced upon
igestion of a full-length JYG-MMTV provirus by the restriction enzymes
, St, and S1S9 have been indicated by arrows. The diagnostic frag-
ents are (1) a 1.4-kb fragment that includes 59 LTR and sequences
pstream to the first PstI site (lane P; B and C); (2) a 1.1-kb gag (lane P;
and D); (3) a 1.5-kb 59 LTR-gag (lane St; B, C, and D): and (4) a 9.7-kb
rovirus (lane S1S9; B, C, and D).not efficiently transform cells in vitro. Therefore, MMTV
pathogenicity must be tested in vivo. To achieve this goal
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328 XU ET AL.for cloned MMTV proviruses, viral constructs are usually
transfected into a suitable cell line, followed by intraperi-
toneal and/or subcutaneous injection of the virus-pro-
ducing cells into susceptible mice (Shackleford and Var-
mus, 1988). One cell line, RBA (ATCC), derived from a rat
mammary adenocarcinoma, has been shown to be suit-
able for MMTV proviral transfection since these cells
have glucocorticoid receptors, but no MMTV-related se-
quences, in their genome. However, it is well known that
cloned MMTVs do not express efficiently in transfected
cells. To boost expression of a hybrid MMTV in trans-
fected cells, Shackleford and Varmus (1988) introduced,
upstream to the MMTV 59 LTR, a 0.3-kb transcriptional
enhancer obtained from Moloney murine leukemia virus
(Mo-MLV). The placement of such an enhancer element
upstream to an MMTV LTR construct has been shown to
result in a 25-fold increase in expression of a reporter
gene in the presence of dexamethasone (Ostrowski et
l., 1984). Taking these observations into account, we
ntroduced a 0.3-kb DNA fragment containing the Mo-
LV enhancer into the JYG-MMTV provirus by linearizing
he proviral construct with SalI (SalI site is located at the
eginning of the 59 LTR). The viral construct was ana-
yzed (data not shown) and found to be suitable for
ransfecting RBA cells. Twenty colonies of stable trans-
ormants were initially picked for expansion and ana-
yzed for the presence of MMTV proviruses by PCR (Fig.
A) using LTR primers. Fifteen of the 20 cell lines were
ound to contain MMTV proviruses (data not shown).
lthough 7 of the MMTV-DNA-positive cell lines were
ound to produce MMTV particles, the results obtained
ith one cell line are shown in the present report.
To test whether the MMTV-DNA-positive RBA cells
roduced JYG-MMTV, culture medium was harvested
rom cells that were treated with 0.7 mM dexamethasone
for 24 h and processed for virus isolation, followed by
viral RNA extraction. RNA samples were then treated
with DNAse in order to eliminate possible DNA contam-
ination and subjected to DNA- and reverse transcriptase
(RT)-PCR analysis using a set of LTR primers that were
designed to amplify the sequences contained within the
39 end of the viral genomic RNA, as well as the SAg-
mRNA. DNA-PCR, done with RNA samples that were
treated with DNase, did not yield any amplification prod-
uct, whereas RT-PCR resulted in the production of a
0.8-kb band representing a 39 segment of the viral
genomic RNA (Fig. 3B). These observations thus indi-
cated that some of our JYG-MMTV-transfected cell lines
were producing MMTV particles.
In order to determine whether the particles produced
by JYG-MMTV transfected cells were infectious in vivo,
we used one JYG-MMTV-producing rat-RBA cell line di-
rectly to infect 4-week-old C58/J 3 CBA/CaJ female mice,
ree of both endogenous and exogenous MMTVs, and
red them (Scherer et al., 1997). The first litter pups of
these rat-cell-injected mice were discarded, but the pups
b
rfrom the second litter (SL) were used for further breed-
ing. This eliminated the possibility of MMTV-infected rat
cells being transported to the offspring of SL mice. The
lack of endogenous MMTV in C58/J 3 CBA/CaJ mice
llowed the direct detection of exogenous MMTV ge-
omes by PCR. Mammary glands, spleen, and bone
arrow of young, third-generation, female SL mice were
ested by DNA-PCR and RT-PCR for the presence of
MTV DNA and the expression of MMTV RNA, respec-
ively. Mammary glands of lactating SL mice from the
hird generation were also analyzed for the presence of
MTV genomic and subgenomic mRNAs. Viral cDNA
as made from total RNA. The DNA-PCR products were
nalyzed by Southern hybridization using an LTR-specific
robe that was prepared by amplifying a 430-bp segment
f JYG-MMTV LTR (LTR position: 470 to 902 bp). This
nternal fragment was chosen as a probe to avoid hy-
FIG. 3. A: Detection of 0.8-kb MMTV proviral DNA in JYG-MMTV
(CL.6) transfected rat RBA Cells by genomic DNA-PCR. PCRs were
carried out with a set of LTR-specific primers, spanning approximately
0.8 kb of the LTR, and 1 mg of cellular DNA. The PCR products were
electrophoresed on a 1.0% agarose gel and stained with ethidium
bromide. For positive controls, plasmid-cloned full-length JYG-MMTV
DNA (1Ctrl) and DNA obtained from the tumor of a JYG mouse infected
with JYG-MMTV (JYG1Ctrl) were used. DNA from nontransfected RBA
cells was used as a negative control (RBA). Note that three of the five
transfected cell lines shown in this illustration contained JYG-MMTV
DNA. B: Detection of MMTV RNA in the medium of transfected rat RBA
cells by RT-PCR. Culture medium from the transfected (clones 1–5) and
nontransfected RBA cells (RBA) were collected, cellular contaminants
were removed by low-speed centrifugation, and the supernatants were
subjected to high-speed centrifugation. RNA was extracted from the
pellets and used for cDNA synthesis. The cDNA was then amplified
and the PCR products were electrophoresed on 1.0% agarose gel and
stained with ethidium bromide. Two positive controls were used: the
PCR product as used in A (1Ctrl) and RNA from a JYG-MMTV-produc-
ing mammary tumor cell line (JYG1Ctrl). RNA from nontransfected RBA
cells were used as a negative control (RBA). Note that one of the
transfected cell lines (clone 1) produced MMTV-RNA.ridization to the primers used for the DNA- and RT-PCR
eactions. Southern blots of the PCR products obtained
t
p
q
o
1
a
i
X
g
t
a
M
g
i
o
a
t
c
c
r
r
t
i
t
J
r
s
S
a
J
w
e
a
329CLONING OF A MILK-BORNE MOUSE MAMMARY TUMOR VIRUSwith the DNA (data not shown) and RNA (Fig. 4A) readily
detected a 0.8-kb MMTV- specific band.
As shown in Fig. 4B, mice infected with cloned JYG-
FIG. 4. Detection of 0.8-kb MMTV RT-PCR products in third-genera-
tion experimental (E) C58/J 3 CBA/CaJ mice (the founder animal did not
carry any endogenous or exogenous MMTV). Total cellular RNA was
prepared from spleen (SP), bone marrow (BM), and mammary glands
(MG) of 2-week-old female mice. Note that the grandmother of these
young animals was infected with cloned JYG-MMTV. Pooled tissue
samples obtained from three animals were used for RNA extraction.
PCRs were done with the 0.8-kb LTR-specific primers using 10 mg of
ellular RNA. Tissues from uninfected mice were used as negative
ontrols (C). The PCR products were electrophoresed on a 1.0% aga-
ose gel and Southern blotted, and the filter was hybridized with a
32P-dCTP-labeled 0.4-kb LTR probe. B: The upper panel shows the
esults of Northern blot analyses of total cellular RNA extracted from
he lactating mammary glands of one control (lane 1) and three exper-
mental (lanes 2–4) C58/J 3 CBA/CaJ mice. The grandmother of the
hird-parity experimental mice was infected with cloned full-length
YG-MMTV proviral DNA. Hybridization was performed with an MMTV-
ep probe. The lower panel shows the result of hybridization of the
ame filter with an actin probe. C: Detection of 0.8-kb MMTV-RNA by
outhern blotting of the RT-PCR products made from the milk of first-
nd second-parity mothers of third-generation of MMTV-infected C58/
3 CBA/CaJ mice. Viral RNA was extracted from the milk and cDNA
as synthesized and amplified by PCR with 0.8-kb LTR-specific prim-
rs. The PCR products were electrophoresed on a 1.0% agarose gel
nd Southern blotted and the filter was hybridized with a 32P-dCTP-
labeled 0.4-kb LTR probe. The positive (1) control PCR was performed
with RNA isolated from the milk of an MMTV-producing JYG mouse,
whereas the negative (2) control PCR was performed with RNA pre-
pared from the milk of an MMTV-uninfected C58/J 3 CBA/CaJ mouse.MMTV expressed the MMTV-specific 8.9-kb genomic
RNA, the 3.6-kb env-mRNA, and the 1.7-kb LTR mRNA in
Ctheir mammary glands. Milk collected from the stomachs
of 2-day-old pups was also tested by RT-PCR for the
presence of viral particles. The results presented in Fig.
4C demonstrate that MMTV was present in the milk of
the virus-infected mice.
DISCUSSION
In this paper we describe for the first time the suc-
cessful cloning of a full-length infectious provirus of
JYG-MMTV. We achieved this goal by surmounting the
two difficult cloning barriers that have hampered the
study of the biology of MMTV. First, the difficulty in
subcloning the gag gene, as shown by Brookes et al.
(1986), was overcome (Xu et al., 1994) by using the
phagemid excision method widely used in cDNA cloning.
The basic principle of phagemid excision is that DNA
cloned into lZapII vector can be automatically excised
with helper phage and recircularized to generate sub-
clones in pBluescript phagemid (Short et al., 1988; Sam-
brook et al., 1989). Our present work demonstrates that
he phagemid excision method allows the cloning into
lasmid of an MMTV provirus that contains “toxic” se-
uences. Further, this method has recently allowed one
f us (L. Xu) to subclone Dd (4.0 kb), a mouse MHC class
I gene (unpublished results) that defied the conventional
insert-ligating method due to the presence of some toxic
sequences in its third exon (Evans et al., 1982; Margulies,
personal communication).
Regarding the second problem, our previous results
clearly indicated that homologous recombinations be-
tween MMTV proviral LTRs can cause partial deletions of
the viral genome, resulting in low recovery of full-length
MMTV proviruses from a genomic DNA library (Xu et al.,
994). As observed previously by many investigators, we
lso found pBluescript SK not to accept the provirus with
ntact 59 and 39 LTRs in certain bacterial hosts, such as
L1-Blue or JM109. The frequent occurrence of homolo-
ous recombinations between the 59 and 39 LTRs of
GR-MMTV, possibly mediated by some bacterial DNA
recombinases, has also been reported (Morris et al.,
1989). The use of SURE as the host cells avoided the
problem of homologous recombination, since they are
less permissive to homologous recombination because
they lack recB, recJ, sbcC, umuC, and uvrC activity. Thus,
hey can be used to clone unstable DNA structures, such
s inverted repeats and Z-DNA (Stratagene).
As mentioned earlier, our restriction map of the JYG-
MTV provirus and the sequencing of the 39 LTR sug-
ested very strongly that our plasmid-cloned provirus is
ntact. Moreover, our biological study of JYG-MMTV dem-
nstrated that the provirus-transfected RBA cells are
ble to produce virus and, more importantly, the virus
hus produced is infectious to endogenous MMTV-free
58/J 3 CBA/CaJ F2 mice.
Since the activation pattern of Wnt/int protooncogenes
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330 XU ET AL.is unique to JYG-MMTV (Sarkar et al., 1994), it is possible
that minor alterations in any of the structural genes of the
JYG-MMTV and/or in the U3 region of its LTR, compared
to other exogeneous MMTVs, may be responsible for the
unique pattern of protooncogene activation in the mam-
mary tumors of JYG mice. Furthermore, the differences in
host cell range observed in various MMTVs may be due
to differences among their env genes. These hypotheses
can now be tested by making hybrid MMTVs by switch-
ing the LTR and/or the env segments between the JYG-
MMTV and other exogenous MMTVs and comparing the
patterns of the hybrid viruses to cell-specific infection
and to the activation of Wnt/int in mammary tumors.
METHODS
DNA and RNA isolation
DNA was isolated from a primary mammary tumor
(developed spontaneously in a JYG mice carrying only
exogenous MMTV), mammary glands, and liver tissues
of endogenous MMTV-free C58/J 3 CBA/CaJ F2 mice of
arious generations, as well as normal RBA rat cells and
he RBA cells that were transfected with a DNA construct
ontaining a full-length copy of JYG MMTV DNA. RNA
as also isolated from these tissues and cells, as well
s from the supernatants of transfected cells. Genomic
NA and total cellular RNA were isolated following the
rotocols that we used previously (Xu et al., 1994; Sarkar
t al., 1994). To obtain a sufficient amount of RNA from
he mammary glands of young mice a pool of four glands
as used.
iral construct
To obtain a full-length copy of JYG-MMTV LTR,
enomic DNA obtained from a mammary tumor of JYG
ice infected with exogenous JYG-MMTV was subjected
o PCR amplification. The following primers were used:
he forward primer, 59(6)-GCGCCTGCAGCAGAAATGGT-
GAA(29)-39, located at the 59 end of the LTR, contained
5 U3-LTR-specific nucleotides with an internal PstI site;
nd the reverse primer, 59(1362)-GATCGAGCTCTGCCG-
AGTCGGCGAAC(1345)-39, located at the 39 end of the
LTR, contained 18 U5-LTR-specific nucleotides plus a
SacI linker, CACGTG, with 4 redundant nucleotides,
GATC. Each 50-ml PCR reaction mixture contained 0.5 mg
of the genomic DNA, 100 ng of each primer, and 1 U Taq
polymerase (Promega). The reaction condition was 10
mM Tris–HCl (pH 9.0), 50 mM NaCl, 1 mM MgCl2, 200
mM dATP, dCTP, dGTP, dTTP in a 50-ml reaction. Cycle
times were 1 min at 95°C, 2 min at 55°C, and 1 min at
72°C. The PCR reactions were carried out using a Per-
kin–Elmer Cetus (Norwalk, CT) PCR DNA thermocycler.
Thirty cycles were performed. The amplified LTR product
(1.33 kb) was double digested with PstI and SacI, gel
purified, and cloned into pBluescript following the
t
wmethod that we described previously (Xu et al., 1994). To
ensure that this PCR-generated LTR clone (Fig. 1, open
boxes) did not suffer from possible deletion of some
nucleotides or any rearrangement, the LTR was se-
quenced using the Sequenase Version 2.0 protocol from
United States Biochemical. Single-strand sequencing
was initiated with the pUC/M13 universal primer and
continued with LTR-specific primers that we used in our
previous work (Xu et al., 1994). As this LTR was found to
be intact, it was used in constructing a full-length JYG-
MMTV (Fig. 1). A 0.3-kb DNA fragment containing the
enhancer element of murine sarcoma virus was also
ligated to the provirus following the strategy used by
Shackleford and Varmus (1988).
Cell transfection
The cloned JYG-MMTV plasmid was used in transfect-
ing RBA cells grown to 50–95% confluency in Dulbecco’s
modified Eagle’s medium with 10% fetal calf serum.
Transfection was carried out at room temperature with 15
mg of the MMTV DNA and 1 mg pPuro DNA by electro-
oration at 320 V, 960 mF (Gene Pulser, Bio-Rad). The
cuvettes were then transferred to an ice bath for 10 min
and the sample gently transferred to six-well plates (Fal-
con, Lincoln Park, NJ). Stable transformants were se-
lected with puromycin (3 mg/ml; Gibco/BRL). The pres-
nce of MMTV sequences in the transfected cells was
xamined by PCR using a second set of LTR primers:
orward primer, 59(209)-GCAGGGCTCTCTCTCACA(226)-
9; reverse primer, 59(997)-TGTTTAGAGGGGACAGTTT-
TA(976)-39.
irus harvest
The MMTV-transfected cells showing the presence of
MTV DNA and the expression of viral RNA were grown
ear confluency and exposed to 0.7 mM dexamethasone
or 24 h, and culture medium was harvested and centri-
uged at 1000g for 30 min. The supernatant was pas-
aged through a 0.2-mm pore-size filter to remove cellu-
ar debris, mixed with 0.5 vol of polyethylene glycol (PEG)
000 (25% PEG 6000, 1.5 M NaCl) at 4°C for 2 h, and
entrifuged again at 12,000g for 20 min at 4°C. RNA was
xtracted from the virus pellet using the TRIzol reagent
Gibco/BRL) and treated with 6 U of RQ DNase (Promega,
adison, WI) for 90 min at 37°C. The DNase was inac-
ivated with an equal volume of 50 mM EDTA, and the
NA was reextracted once with phenol–chloroform, pre-
ipitated with ethanol, and resuspended in 30 ml of
diethyl pyrocarbonate-treated water.
RT-PCR
RT-PCR was done on the second set of LTR primers.
The reactions were carried out with 5 ml of DNase-
reated RNA. No amplification of any specific DNA band
as seen. Viral cDNA was made from 25 ml total RNA
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331CLONING OF A MILK-BORNE MOUSE MAMMARY TUMOR VIRUSusing the second set LTR reverse primer. Each 50-ml
reverse transcription reaction mixture contained 50 mM
Tris, 75 mM KCl, 3 mM MgCl2, 600 mM dithiothreitol, 150
mM of each deoxynucleotide triphosphate, 66.4 mM LTR
rimer, 25 U of RNAguard (Pharmacia Biotech), and 130
of Moloney murine leukemia virus reverse tran-
criptage (Gibco/BRL). Second-strand synthesis was
arried out with 5 ml of cDNA with the LTR primers
described above.
In vivo virus infection assay
The usual test for the infectivity of MMTV in mice is
performed by intraperitoneal inoculation of concentrated
viral preparations. Shackleford and Varmus (1988) have
shown that MMTV-producing rat cells can also be inoc-
ulated into mice to establish virus infection. In the
present study, JYG-MMTV-producing rat cells were
grown in the presence of 0.7 mM dexamethasone for
24 h, resuspended in 1 ml (107 cells) of phosphate-
uffered saline containing 5 mM dexamethasone, and
njected into female endogenous MMTV-free C58/J 3
BA/CaJ mice subcutaneously and intraperitoneally. The
njections were repeated three times over a period of 2
eeks, and the mice were then bred. The first-litter pups
f these rat-cell-injected mice were discarded to elimi-
ate the possibility of MMTV-infected rat cells being
ransported to the offspring. Pups from the second litter
ere used for breeding.
outhern hybridization
The expression of MMTV RNA in cultured cells and in
arious mouse tissues was detected by Southern hybrid-
zation. Viral cDNA was made from total RNA; the DNA-
CR was carried out by using 5 ml cDNA from the 50-ml
RT reaction. The PCR products were separated on a 1.0%
agarose gel, blotted, and hybridized with a 430-bp 32P-
labeled LTR probe. The probe (LTR position: 470 to 902
bp) was amplified by PCR, using the forward primer
59(470)-CAGATTCAGAGGTTAGAAATGGG(493)-39 and the
reverse primer 59(902)-AGCTCCCTCTTCTGTATAATC(981)-
39. This internal fragment was chosen as a probe to
avoid hybridization to the primers used for the DNA- and
RT-PCR reactions.
Northern hybridization
Mammary glands obtained from control and experi-
mental lactating mice were analyzed for the presence of
MMTV genomic and subgenomic mRNAs following a
procedure similar to that which we described previously
(Li et al., 1994). Briefly, RNA was extracted with 6 M
urea–3 M LiCl and denatured at 65°C for 10 min in a
solution containing 50% (w/w) formamide, 2.2 M formal-
dehyde, and RNA electrophoresis buffer consisting of 20
mM Mops (morpholinepropanesulfonic acid, pH 7.0), 5
mM sodium acetate, and 1 mM EDTA. The RNA samples(20 mg/lane) were then electrophoresed in 1% agarose
gel (buffer: 2000 mM Mops, 500 mM NaOAc, 100 mM
EDTA, 4% formaldehyde), transferred to a Zeta probe filter
in the presence of 203 SSC, and UV cross-linked. The
filter was then hybridized with approximately 5 3 107
cpm/ml of a radioactive full-length MMTV probe for 24 h
at 65°C in a solution containing 0.2 M Na2HPO4, 1 mM
EDTA, 1% BSA, 7% SDS, and 16% formamide. The filter
was washed three times, 25 min each, in a solution of 0.4
M Na2HPO4, 5% SDS, and 0.001 mM EDTA at 65°C and
exposed to Kodak X-ray film at 280°C. The radioactive
probe was then stripped (dehybridized) from the filter
and rehybridized with a chicken b-actin probe to ensure
hat equivalent amounts of RNA from control and exper-
mental samples were loaded on each lane of the gel.
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